deferoxamine has been researched along with Iron Metabolism Disorders in 11 studies
Deferoxamine: Natural product isolated from Streptomyces pilosus. It forms iron complexes and is used as a chelating agent, particularly in the mesylate form.
desferrioxamine B : An acyclic desferrioxamine that is butanedioic acid in which one of the carboxy groups undergoes formal condensation with the primary amino group of N-(5-aminopentyl)-N-hydroxyacetamide and the second carboxy group undergoes formal condensation with the hydroxyamino group of N(1)-(5-aminopentyl)-N(1)-hydroxy-N(4)-[5-(hydroxyamino)pentyl]butanediamide. It is a siderophore native to Streptomyces pilosus biosynthesised by the DesABCD enzyme cluster as a high affinity Fe(III) chelator.
Iron Metabolism Disorders: Disorders in the processing of iron in the body: its absorption, transport, storage, and utilization. (From Mosby's Medical, Nursing, & Allied Health Dictionary, 4th ed)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (45.45) | 18.7374 |
| 1990's | 1 (9.09) | 18.2507 |
| 2000's | 2 (18.18) | 29.6817 |
| 2010's | 3 (27.27) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Badat, M | 1 |
| Kaya, B | 1 |
| Telfer, P | 1 |
| Pelucchi, S | 1 |
| Pelloni, I | 1 |
| Arosio, C | 1 |
| Mariani, R | 1 |
| Piperno, A | 1 |
| Pan, PL | 1 |
| Tang, HH | 1 |
| Chen, Q | 1 |
| Song, W | 1 |
| Shang, HF | 1 |
| Traore, HN | 1 |
| Meyer, D | 1 |
| PITTMAN, AK | 2 |
| BARR, DG | 1 |
| FRASER, DK | 1 |
| BURLEY, DM | 1 |
| FIELDING, J | 1 |
| CHAVANNE, H | 1 |
| DEMILLIERE, B | 1 |
| Beard, JL | 1 |
| Wiesinger, JA | 1 |
| Jones, BC | 1 |
| Miyajima, H | 1 |
| Takahashi, Y | 1 |
| Kamata, T | 1 |
| Shimizu, H | 1 |
| Sakai, N | 1 |
| Gitlin, JD | 1 |
1 trial available for deferoxamine and Iron Metabolism Disorders
| Article | Year |
|---|---|
Use of desferrioxamine in the treatment of aceruloplasminemia.
Topics: Ceruloplasmin; Deferoxamine; Diabetes Mellitus, Type 2; Female; Humans; Iron; Iron Metabolism Disord | 1997 |
10 other studies available for deferoxamine and Iron Metabolism Disorders
| Article | Year |
|---|---|
Combination-therapy with concurrent deferoxamine and deferiprone is effective in treating resistant cardiac iron-loading in aceruloplasminaemia.
Topics: Adult; Ceruloplasmin; Deferiprone; Deferoxamine; Drug Therapy, Combination; Heart Diseases; Humans; | 2015 |
Does aceruloplasminemia modulate iron phenotype in thalassemia intermedia?
Topics: alpha-Globins; Base Sequence; beta-Globins; beta-Thalassemia; Ceruloplasmin; Deferoxamine; Exons; Ge | 2016 |
Desferrioxamine treatment of aceruloplasminemia: Long-term follow-up.
Topics: Brain; Ceruloplasmin; Deferoxamine; Female; Humans; Iron Metabolism Disorders; Longitudinal Studies; | 2011 |
Comparing qualitative and quantitative spectroscopic techniques for the detection of the effect of direct iron loading of mammalian cell cultures.
Topics: Cell Culture Techniques; Cell Death; Cell Survival; Coloring Agents; Deferoxamine; Ferric Compounds; | 2001 |
DESFERRIOXAMINE AND ACUTE IRON POISONING.
Topics: Deferoxamine; Heavy Metal Poisoning; Injections, Intramuscular; Iron; Iron Metabolism Disorders; Met | 1964 |
DESFERRIOXAMINE AND ACUTE IRON POISONING.
Topics: Deferoxamine; Heavy Metal Poisoning; Iron; Iron Metabolism Disorders; Metals, Heavy; Poisoning; Toxi | 1964 |
MANAGEMENT OF ACUTE IRON POISONING.
Topics: Chemical and Drug Induced Liver Injury; Deferoxamine; Hepatitis; Hepatitis A; Iron; Iron Metabolism | 1965 |
MANAGEMENT OF ACUTE IRON POISONING.
Topics: Deferoxamine; Drug Therapy; Heavy Metal Poisoning; Iron; Iron Metabolism Disorders; Metals, Heavy; P | 1965 |
[TRIAL OF A NEW IRON CHELATOR, DESFERRIOXAMINE B, IN A CASE OF OCULAR SIDEROSIS].
Topics: Chelating Agents; Deferoxamine; Eye Diseases; Heavy Metal Poisoning; Humans; Iron; Iron Metabolism D | 1964 |
Cellular iron concentrations directly affect the expression levels of norepinephrine transporter in PC12 cells and rat brain tissue.
Topics: Animals; Brain; Deferoxamine; Disease Models, Animal; Dose-Response Relationship, Drug; Food, Formul | 2006 |